BTIG Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $70

BTIG analyst Marie Thibault has initiated coverage on Pulse Biosciences (NASDAQ: PLSE) with a Buy rating. The firm has set a price target of $70 for the company's stock.